
MD Biosciences is accredited by AAALAC International, demonstrating globally recognized excellence in animal care beyond regulatory standards.
At MD Biosciences, we recognize the transformative impact of your research in changing lives. Whether targeting CNS disorders, pain, or wound healing, your therapies can revolutionize patient care. With over 30 years of expertise as a contract research organization (CRO), we offer methodologies to enhance the clinical relevance of your preclinical data and accelerate your path to breakthrough treatments. Our collaborative efforts have advanced new drugs into the clinic and earned recognition in leading scientific publications.
Our scientists excel in designing and executing complex studies across therapeutic areas. We deliver cutting-edge methodologies and key insights to maximize the value and clinical relevance of your research.

MD Biosciences is accredited by AAALAC International, demonstrating globally recognized excellence in animal care beyond regulatory standards.

Our 20,000 square foot GLP facility supports translational research with dedicated rodent and pig labs, histology, biomarker, electrophysiology, and in vitro capabilities.

MD Biosciences holds an NIH Office of Laboratory Animal Welfare Foreign Assurance, confirming compliance with NIH animal care standards and enabling support of NIH-funded research conducted outside the United States.
MD Biosciences is a signatory to the Marseille Declaration, the first collective pharmaceutical industry commitment to advancing standards in animal housing and care. This reflects our dedication to maintaining the highest levels of animal welfare.
MD Biosciences is at the forefront of developing translational pig models, pioneering advanced methodologies and novel quantitative measures to de-risk clinical trials and drive success in neuroscience and pain research.